At Physiomics, we believe in the importance of strong partnerships and collaborations.
With over 70 successfully completed projects to date, we have partnered with top pharmaceutical and biotech companies as well as leading research organisations and academic institutions.
We believe collaborations are a vital component of driving innovation, change, continuous improvement and growth. So, whether you’re a small research facility or a large pharmaceutical, if you’d like to learn more we’d love to hear from you.
Why Partner with Us?
When you partner with Physiomics, you’re partnering with a company that focuses exclusively on cancer.
Our team of passionate specialists have a wealth of knowledge and experience in cancer biology, quantitative pharmacology and mathematical modelling.
We are agile, collaborative and responsive… with experience working across large company structures as well as with smaller commercial and not-for profit clients.
We have collectively, accumulated over 100 years of experience in pre-clinical and clinical oncology drug development [Meet the Team].
We support all phases of drug development R&D, helping our Partners accelerate drug development whilst minimizing costs, with a strong track record of success.
Interested in speaking with a consultant?
We’ll arrange a brief consultation for you with a specialist in our team.